Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1999
11/09/1999US5981704 Kainate-binding, human CNS receptors of the EAA2 family
11/09/1999US5981701 Tumor necrosis factor inhibitory protein and its purification
11/09/1999US5981700 Polypeptide antigen encoded by dna insert; for sensitive diagnostic immunoassay for screening prediabetic state; antidiabetic agents
11/09/1999US5981698 Antimicrobial polypeptides
11/09/1999US5981697 Synthetic peptides, antibodies against them and their use
11/09/1999US5981606 Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
11/09/1999US5981602 Ajoene inhibits the growth of hiv-infected cells, hiv, and other viruses, also inhibits the incorporation of hiv into cd4-negative cells
11/09/1999US5981594 Method of treatment for diabetic neuropathy
11/09/1999US5981589 Copolymer-1 improvements in compositions of copolymers
11/09/1999US5981583 For use in the treatment of pathological conditions such as toxic shock, acute inflammatory conditions, acute phase response, atherosclerosis and cancer
11/09/1999US5981569 Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
11/09/1999US5981546 Integrin antagonists
11/09/1999US5981508 Facilitation of repair of neural injury with CM101/GBS toxin
11/09/1999US5981502 Methods and compositions for inducing apoptosis in tumor cells
11/09/1999US5981493 Administering to the human suffering from aids an unconjugated double chain ribosomal inactivating protein selected from ricin, abrin, modeccin, viscumin and volkensin
11/09/1999US5981492 Substituted 5-membered ring heterocycles, their preparation and their use
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981489 Nonaqueous peptide compound which consists essentially of about 30% to about 50% (w/w) of the lhrh-related compound leuprolilde acetate in polyoxyethylene glcol or mixture
11/09/1999US5981488 Polypeptide; antidiabetic agent
11/09/1999US5981487 Method of inhibiting smooth muscle cell proliferation
11/09/1999US5981486 Peptide suppressing IκBα phosphorylation
11/09/1999US5981485 Contains human growth hormone, a buffer, a non-ionic surfactant, and a neutral salt free of glycine and mannitol and have improved storage stability
11/09/1999US5981484 Administering to a human in need of antiangiogenesis therapy an effective amount of mammalian kringle 5 peptide fragment
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981482 Interleukin-1 receptor intracellular ligand proteins
11/09/1999US5981481 Amino acid sequence lacking a transmembrane region; useful as antiinflammatory agent, diagnosis of autoimmune disorder
11/09/1999US5981480 Pantropic neurotrophic factors
11/09/1999US5981479 Administering to the aids patient a nonimmunosuppressive, cyclophilin-bining cyclosporin which binds to human genetic engineered cyclophilin and has an activity in the mixed lymphocyte reaction of not more than 10% that of ciclosporin
11/09/1999US5981478 Integrin-binding peptides
11/09/1999US5981477 Peptide-metal chelate conjugates
11/09/1999US5981476 Method for treating bladder cancer with a keyhole limpet hemocyanin composition having enhanced anti-tumor activity
11/09/1999US5981475 Treatment for sensitive teeth
11/09/1999US5981474 Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same
11/09/1999US5981473 Composition and method for treating acne
11/09/1999US5981472 Methods for treating diseases
11/09/1999US5981471 Administering to human or animal tissue factor pathway inhibitor to inhibit endothelial cell proliferation
11/09/1999US5981470 Administering pharmaceutical agent selected from the group consisting of an angiotensin converting enzyme inhibitor, an angiotensin ii-receptor antagonist, a renin inhibitor, and an angiotensin ii-receptor expression inhibitor
11/09/1999US5981469 As antimicrobial drug, anticarcinogenic agent
11/09/1999US5981468 Conformationally stabilized cell adhesion peptides
11/09/1999US5981279 Compositions and methods to regulate calmodulin gene expression, and uses thereof for influencing cell growth and differentiation
11/09/1999US5981278 Immunoglobulin which binds to a peptide which is part of the an envelope protein of the acquired immunodeficiency virus; viricide; for vaccine development
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999US5981276 Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
11/09/1999US5981265 Controlling mitogen kinase polypeptide activity in a cell using transformation and transfection; for treating animals having cancer, inflammation, neurological disorders, autoimmune diseases, allergiies; anticarcinogenic agents
11/09/1999US5981264 Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
11/09/1999US5981263 Nucleotide sequence coding a polypeptide extracellular matrix protein; for diagnosis, prevention, and treatment of vesicle trafficking, developmental, neoplastic and immunological defects; anticarcinogenic agents; antitumor agents
11/09/1999US5981262 Nucleotide sequence coding a mammalian tyrosine kinase; for study of signal transduction pathway; for treatment of allergies and asthma; antiinflammatory agents
11/09/1999US5981261 Pure culture for production of bacteriocin, for preparing foodstuffs such as sausages and cosmetics
11/09/1999US5981258 Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect
11/09/1999US5981256 Recombinant stratum corneum chymotryptic enzyme (SCCE)
11/09/1999US5981254 Salting out plasma proteins, diafiltering and diluting supernatant containing prothrombin, acidic precipitation, solubilizing, converting to thrombin, deactivating lipid containing viruses, chromatographic purification; safe glues
11/09/1999US5981252 Enzyme for diagnosis of atherosclerosis; for screening enzyme inhibitors as therapy
11/09/1999US5981251 PTP 1D: a novel protein tyrosine phosphatase
11/09/1999US5981248 Amino acid and nucleotide sequences coding for kinase involved in apoptosis; prevention of acidental cell death
11/09/1999US5981246 Nucleic acids encoding EPH-like receptor protein tyrosine kinases
11/09/1999US5981245 Polypeptide kinase coded by a nucleic acid sequence; antibody development; for modulating kinase receptor activation and detecting receptor ligands
11/09/1999US5981244 Human aflatoxin B1 aldehyde reductase
11/09/1999US5981242 Transport protein for diagnosing or preventing a cell proliferation diseases, autoimmune/inflammatory disorder, cancer; anticarcinogenic/antiproliferative/antiarthritic agents
11/09/1999US5981229 For passive immune therapy; for diagnosis and prevention of grampositive bacterial infection; for prevention of infection by antibiotic resistant microoganisms
11/09/1999US5981222 Mammalian polynucleotide encoding protein factor; for disease prevention and treatment
11/09/1999US5981221 Histone fusion protein
11/09/1999US5981220 Nucleotide sequences coding protein associated with skin differentiation; diagnostic assays for detecting bone and skin disorders; treatment of osteoporosis, bone fractures
11/09/1999US5981213 Dna sequence coding microorganism outer membrane protein; detect the presence of antigens and/or antibodies in a sample; vaccine development
11/09/1999US5981205 Nuclear Dbf2- related (Ndr) kinases
11/09/1999US5981201 Methods of detection and treatment of breast cancer
11/09/1999US5981197 Detecting or measuring basic fibroblast growth factor using immunoglobulin; activating cell propagation; therapy for thrombosis and arteriosclerosis
11/09/1999US5981195 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors
11/09/1999US5981194 Determining or monitoring alzheimer's disease in patients suspected of having alzheimer's disease; measuring the concentration of protein marker in sample and compare it a control; monitoring therapies for alzheimer's disease
11/09/1999US5981192 Hybridizing complementary nucleotide sequences, removing unhybridized portion, detecting said hybridization complex; diagnosis of cancer and immune diseases
11/09/1999US5981172 Probe for viral untranslated region; detecting viral nucleic acids; deveolping vaccines and antibodies to use as diagnostic tool in detecting presence of virus
11/09/1999US5981170 Diagnostic immunoassay kit for detection of antibodies induced by human immunodeficiency virus in sample of body fluid; includes artificial peptide of an epitope having a cystine bridge
11/09/1999US5981165 Exogenous activation and expression of tyrosine hydroxylase in neural cells; culturing mammalian cells of central nervous system; treatment for parkinson's disease and other nervous system disorders
11/09/1999US5980939 Cyclosporin-containing pharmaceutical composition
11/09/1999US5980913 A tetrapeptides as vaccine adjuvant
11/09/1999US5980911 Enhancing an immune synergy response to an antigen comprising the administration of at least two cytokines
11/09/1999US5980910 Useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, in assays for the detection of such bacteria
11/09/1999US5980906 Live recombinant avian vaccine using an avian herpesvirus as vector
11/09/1999US5980899 Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
11/09/1999US5980897 Treating mammals suffering from infections caused by gram-negative bacteria
11/09/1999US5980896 Antibodies reactive with human carcinomas
11/09/1999US5980895 Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation
11/09/1999US5980894 A monoclonal antibody therapeutic agents that specifically binds human leukemia inhibitory factor and neutralizes a biological activity of human leukemia inhibitory
11/09/1999US5980893 Treating thrombocytopenia and stimulating proliferation of primary bone marrow megakaryocytes
11/09/1999US5980892 Increasing cytotoxicity by exposing t lymphocytes to a monoclonal antibody, reacting with an epitope of the variable region of a t cell antigen receptor; treating rheumatoid arthritis
11/09/1999US5980887 Methods for enhancing angiogenesis with endothelial progenitor cells
11/09/1999US5980886 Recombinant vectors for reconstitution of liver
11/09/1999US5980885 Growth factor-induced proliferation of neural precursor cells in vivo
11/09/1999US5980884 Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
11/09/1999CA2136565C Polypeptide of protein p140 and dnas encoding it
11/09/1999CA1340817C Recombinant flagellin vaccines
11/09/1999CA1340815C Hybridomas producing monoclonal antibodies to new mucin epitopes
11/06/1999CA2270847A1 Alpha-ketoamide derivatives
11/06/1999CA2236989A1 Novel therapy for treatment of lysosomal storage disease
11/04/1999WO1999056129A1 Methods of selecting internalizing antibodies
11/04/1999WO1999055911A1 Identifying peptide ligands of target proteins with target complementary library technology (tclt)
11/04/1999WO1999055900A2 Gcp
11/04/1999WO1999055876A2 Polypeptide with immunogenic properties and with a protein with modified biological functions
11/04/1999WO1999055873A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999WO1999055871A1 Polypeptides from moraxella (branhamella) catarrhalis
1 ... 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 ... 3163